White cell and platelet content affects the release of bioactive factors in different blood-derived scaffolds

References

• Burnouf T, Goubran HA, Chen TM, Ou KL, El-Ekiaby M, Radosevic M. Blood-derived biomaterials and platelet growth factors in regenerative medicine. Blood Rev 2013;27(2):77–89.
   PubMed Web of Science ®Google Scholar
• Bielecki T, Dohan Ehrenfest DM. Platelet-rich plasma (PRP) and Platelet-Rich Fibrin (PRF): surgical adjuvants, preparations for in situ regenerative medicine and tools for tissue engineering. Curr Pharm Biotechnol 2012;13(7):1121–1130.
   PubMed Web of Science ®Google Scholar
• Marx RE, Carlson ER, Eichstaedt RM, Schimmele SR, Strauss JE, Georgeff KR. Platelet-rich plasma: growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998;85(6):638–646.
   PubMed Web of Science ®Google Scholar
• Sammartino G, Dohan Ehrenfest DM, Carile F, Tia M, Bucci P. Prevention of hemorrhagic complications after dental extractions into open heart surgery patients under anticoagulant therapy: the use of leukocyte- and platelet-rich fibrin. J Oral Implantol 2011;37(6):681–690.
   PubMed Web of Science ®Google Scholar
• Picard F, Hersant B, Bosc R, Meningaud JP. The growing evidence for the use of platelet-rich plasma on diabetic chronic wounds: A review and a proposal for a new standard care. Wound Repair Regen 2015;23(5):638–643.
   PubMed Web of Science ®Google Scholar
• Del Corso M, Vervelle A, Simonpieri A, Jimbo R, Inchingolo F, Sammartino G. Current knowledge and perspectives for the use of platelet-rich plasma (PRP) and platelet-rich fibrin (PRF) in oral and maxillofacial surgery part 1: periodontal and dentoalveolar surgery. Curr Pharm Biotechnol 2012;13(7):1207–1230.
   PubMed Web of Science ®Google Scholar
• Leo MS, Kumar AS, Kirit R, Konathan R, Sivamani RK. Systematic review of the use of platelet-rich plasma in aesthetic dermatology. J Cosmet Dermatol 2015;14(4):315–323.
   PubMed Web of Science ®Google Scholar
• Dohan Ehrenfest DM, Andia I, Zumstein MA, Zhang CQ, Pinto NR, Bielecki T. Classification of platelet concentrates (Platelet-Rich Plasma-PRP, Platelet-Rich Fibrin-PRF) for topical and infiltrative use in orthopedic and sports medicine: current consensus, clinical implications and perspectives. Muscles Ligaments Tendons J 2014;4(1):3–9.
   PubMedGoogle Scholar
• Dohan Ehrenfest DM, Sammartino G, Shibli JA, Wang HL, Zou DR, Bernard JP. Guidelines for the publication of articles related to platelet concentrates (Platelet-Rich Plasma - PRP, or Platelet-Rich Fibrin - PRF): the international classification of the POSEIDO. POSEIDO 2013;1(1):17–27.
   Google Scholar
• Reed GL. Platelet secretory mechanisms. Semin Thromb Hemost 2004;30(4):441–450.
   PubMed Web of Science ®Google Scholar
• Lubkowska A, Dolegowska B, Banfi G. Growth factor content in PRP and their applicability in medicine. J Biol Regul Homeost Agents 2012;26:3S–22S.
   PubMedGoogle Scholar
• Scarano A, Ceccarelli M, Marchetti M, Piattelli A, Mortellaro C. Soft tissue augmentation with autologous platelet gel and β-TCP: a histologic and histometric study in mice. Biomed Res Int 2016;12:2016:2078104.
   Google Scholar
• Demidova-Rice TN, Wolf L, Deckenback J, Hamblin MR, Herman IM. Human platelet-rich plasma- and extracellular matrix-derived peptides promote impaired cutaneous wound healing in vivo. Plos One 2012;7:e32146.
   PubMed Web of Science ®Google Scholar
• Intini G. The use of platelet-rich plasma in bone reconstruction therapy. Biomaterials 2009;30(28):4956–4966.
   PubMed Web of Science ®Google Scholar
• Lacci KM, Dardik A. Platelet-rich plasma: support for its use in woundhealing. Yale J Biol Med 2010;83(1):1–9.
   PubMedGoogle Scholar
• Rozman P, Bolta Z. Use of platelet growth factors in treating wounds and soft-tissue injuries. Acta Dermatovenerol Alp Pannonica Adriat 2007;16(4):156–165.
   PubMedGoogle Scholar
• David M, Dohan E, Tomasz B, Allan M, Piero B, Francesco I, Gilberto S, Lars R, Peter A. everts in search of a consensus terminology in the field of platelet concentrates for surgical use: Platelet-Rich Plasma (PRP), Platelet-Rich Fibrin (PRF), Fibrin Gel Polymerization and Leukocytes. Curr Pharm Biotechnol 2012;12:1131–1137.
   Google Scholar
• Cieslik-Bielecka A, Dohan Ehrenfest DM, Lubkowska A, Bielecki T. Microbicidal properties of Leukocyte- and Platelet-Rich Plasma/Fibrin (L-PRP/L-PRF): new perspectives. J Biol Regul Homeost Agents 2012;26(2 Suppl 1):43S–52S.
   PubMedGoogle Scholar
• Prakash S, Thakur A. Platelet concentrates: past, present and future. J Maxillofac Oral Surg 2011;10(1):45–49.
   PubMedGoogle Scholar
• Borzini P, Balbo V, Mazzucco L. Platelet concentrates for topical use: bedside device and blood transfusion technology. Quality and versatility. Curr Pharm Biotechnol 2012;13(7):1138–1144.
   PubMed Web of Science ®Google Scholar
• Passaretti F, Tia M, D’Esposito V, De Pascale M, Del Corso M, Sepulveres R, Liguoro D, Valentino R, Beguinot F, Formisano P, Sammartino G. Growth-promoting action and growth factor release by different platelet derivatives. Platelets 2014;25(4):252–256.
   PubMed Web of Science ®Google Scholar
• D’Esposito V, Passaretti F, Perruolo G, Ambrosio MR, Valentino R, Oriente F, Raciti GA, Nigro C, Miele C, Sammartino G, Beguinot F, Formisano P. Platelet-rich plasma increases growth and motility of adipose tissue-derived mesenchymal stem cells and controls adipocyte secretory function. J Cell Biochem 2015;116(10):2408–2418.
   PubMed Web of Science ®Google Scholar
• Anitua E, Sánchez M, Zalduendo MM, De La Fuente M, Prado R, Orive G, Andía I. Fibroblastic response to treatment with different preparations rich in growth factors. Cell Prolif 2009;42(2):162–170.
   PubMed Web of Science ®Google Scholar
• Anitua E, Alonso R, Girbau C, Aguirre JJ, Muruzabal F, Orive G. Antibacterial effect of plasma rich in growth factors (PRGF®-Endoret®) against Staphylococcus aureus and Staphylococcus epidermidis strains. Clin Exp Dermatol. 2012;37(6):652–657.
   PubMed Web of Science ®Google Scholar
• Anitua E, Zalduendo MM, Prado R, Alkhraisat MH, Orive G. Morphogen and proinflammatory cytokine release kinetics from PRGF-Endoret fibrin scaffolds: evaluation of the effect of leukocyte inclusion. J Biomed Mater Res A. 2015;103(3):1011–1020.
   PubMed Web of Science ®Google Scholar
• Anitua E, Prado R, Troya M, Zalduendo M, De La Fuente M, Pino A, Muruzabal F, Orive G. Implementation of a more physiological plasma rich in growth factor (PRGF) protocol: anticoagulant removal and reduction in activator concentration. Platelets 2016;27(5):459–466.
   PubMed Web of Science ®Google Scholar
• Dohan DM, Choukroun J, Diss A, Dohan SL, Dohan AJ, Mouhyi J, Gogly B. Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part II: platelet-related biologic features. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006;101(3):e45–50.
   PubMed Web of Science ®Google Scholar
• Marenzi G, Riccitiello F, Tia M, di Lauro A, Sammartino G. Influence of Leukocyte- and Platelet-Rich Fibrin (L-PRF) in the healing of simple postextraction Sockets: a Split-Mouth Study. Biomed Res Int 2015;2015:369273.
   Google Scholar
• Dohan Ehrenfest DM, Rasmusson L, Albrektsson T. Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF). Trends Biotechnol 2009;27(3):158–167.
   PubMed Web of Science ®Google Scholar
• Ghanaati S, Booms P, Orlowska A, Kubesch A, Lorenz J, Rutkowski J, Landes C, Sader R, Kirkpatrick C, Choukroun J. Advanced platelet-rich fibrin: a new concept for cell-based tissue engineering by means of inflammatory cells. J Oral Implantol 2014;40(6):679–689.
   PubMed Web of Science ®Google Scholar
• Smyth SS, McEver RP, Weyrich AS, Morrell CN, Hoffman MR, Arepally GM, French PA, Dauerman HL, Becker RC. 2009 Platelet colloquium participants. Platelet Functions beyond Hemostasis. J Thromb Haemost 2009;7(11):1759–1766.
   PubMed Web of Science ®Google Scholar
• Weyrich AS, Zimmerman GA. Platelets: signaling cells in the immune continuum. Trends Immunol 2004;25(9):489–495.
   PubMed Web of Science ®Google Scholar
• Van Dooren FH, Duijvis NW. te Velde AA. Analysis of cytokines and chemokines produced by whole blood, peripheral mononuclear and polymorphonuclear cells. J Immunol Methods 2013; 396 (1–2): 128–133.
   Google Scholar
• Loffredo S, Staiano RI, Granata F, Genovese A, Marone G. Immune cells as a source and target of angiogenic and lymphangiogenic factors. Chem Immunol Allergy 2014;99:15–36.
   PubMedGoogle Scholar
• Saaristo A, Tammela T, Farkkilā A, Kärkkäinen M, Suominen E, Yla-Herttuala S, Alitalo K. Vascular endothelial growth factor-C accelerates diabetic wound healing. Am J Pathol 2006;169(3):1080–1087.
   PubMed Web of Science ®Google Scholar
• Bao P, Kodra A, Tomic-Canic M, Golinko MS, Ehrlich HP, Brem H. The role of vascular endothelial growth factor in wound healing. J Surg Res 2009;153(2):347–358.
   PubMed Web of Science ®Google Scholar
• Kobayashi E, Flückiger L, Fujioka-Kobayashi M, Sawada K, Sculean A, Schaller B, Miron RJ. Comparative release of growth factors from PRP, PRF, and advanced-PRF. Clin Oral Investig 2016;20(9):2353–2360 [Epub ahead of print].
   PubMed Web of Science ®Google Scholar
• Marques RE, Guabiraba R, Russo RC, Teixeira MM. Targeting CCL5 in inflammation. Expert Opin Ther Targets 2013;17(12):1439–1460.
   PubMed Web of Science ®Google Scholar
• Salcedo R, Young HA, Ponce ML, Ward JM, Kleinman HK, Murphy WJ, Oppenheim JJ. Eotaxin (CCL11) induces in vivo angiogenic responses by human CCR3+ endothelial cells. J Immunol 2001;166(12):7571–7578.
   PubMed Web of Science ®Google Scholar
• Suffee N, Hlawaty H, Meddahi-Pelle A, Maillard L, Louedec L, Haddad O, Martin L, Laguillier C, Richard B, Oudar O, Letourneur D, Charnaux N, Sutton A. RANTES/CCL5-induced pro-angiogenic effects depend on CCR1, CCR5 and glycosaminoglycans. Angiogenesis 2012;15(4):727–744.
   PubMed Web of Science ®Google Scholar
• Galliera E, Corsi MM, Banfi G. Platelet rich plasma therapy: inflammatory molecules involved in tissue healing. J Biol Regul Homeost Agents 2012;26(2 Suppl 1):35S–42S.
   PubMedGoogle Scholar
• Jalowiec JM, D’Este M, Bara JJ, Denom J, Menzel U, Alini M, Verrier S, Herrmann M. An In Vitro Investigation of Platelet-Rich Plasma-Gel as a Cell and Growth Factor Delivery Vehicle for Tissue Engineering. Tissue Eng Part C Methods 2016;22(1):49–58.
   PubMed Web of Science ®Google Scholar
• Anitua E, Sánchez M, Orive G, Andía I. The potential impact of the preparation rich in growth factors (PRGF) in different medical fields. Biomaterials 2007;28(31):4551–4560.
   PubMed Web of Science ®Google Scholar